InvestorsHub Logo
Followers 14
Posts 698
Boards Moderated 0
Alias Born 04/06/2011

Re: None

Monday, 06/01/2020 11:17:29 AM

Monday, June 01, 2020 11:17:29 AM

Post# of 16703
Sorry to tell some here but AGN is a speculative stock. They are not Giliad with Remdesivir or Trump pumped Coloquin (sp?) with billions of $ for lawyers and truth bending advertisement.
AGN will need to have all the ducks in nice rows. S Korea appears to be silent which I expected. AGN is not a sponsor on this trial from what Dr Moreau said in the past. This is a Korean led investigational study, right?
Seems like it is vogue now to claim even mild results as great. The NDMA/ Sr1 antagonist angle is AGN's. Others have documented the science. I have bought my share and will await news from the several paths worldwide where experienced other scientists are taking seriously the possibilities of Ifenprodil presented by AGN and supporting Phase2/2b to 3 Clinical trials. Korea might be fully in process.
AGN has set up Trials for CC/IPF and now COVID and is producing the intravenous form of Ifenprodil along with having the 20mg pill form.
Not bad for a $2 bit bet, I'll let my money ride without genuflecting contortions to other's...GLTA...

BTW, 7 days to NOVOTECH Asia clinical trials update forum.